electroCore (ECOR) Long-Term Debt Repayments (2019 - 2020)
electroCore's quarterly Long-Term Debt Repayments came in at $489682.0 in Q4 2020, up 40.12% year-on-year from $349463.0 in Q1 2020, and down 0.97% quarter-over-quarter from $494496.0 in Q3 2020.
electroCore has reported Long-Term Debt Repayments for 2 years, with the latest figure at $489682.0 in Q4 2020.
- For the quarter ending Q4 2020, Long-Term Debt Repayments rose 40.12% year-over-year to $489682.0; the trailing twelve-month figure through Dec 2020 stood at $1.1 million (changed N/A YoY), and the FY2020 full-year result was $1.1 million, up 57.6% from the prior year.
- Long-Term Debt Repayments for Q4 2020 stood at $489682.0, down from $494496.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $494496.0 in Q3 2020, with the low at $111878.0 in Q1 2020.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | electroCore | 92,394.96 | -8.79 Mn | 8.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 489,682.00 |
| Dec 31, 2020 | 489,682.00 |
| Sep 30, 2020 | 494,496.00 |
| Sep 30, 2020 | 494,496.00 |
| Mar 31, 2020 | 111,878.00 |
| Mar 31, 2020 | 111,878.00 |
| Dec 31, 2019 | 349,463.00 |
| Dec 31, 2019 | 349,463.00 |